OTLK
OUTLOOK THERAPEUTICS INC
NASDAQ: OTLK · HEALTHCARE · BIOTECHNOLOGY
$0.25
-2.50% today
Updated 2026-04-30
Market cap
$34.41M
P/E ratio
—
P/S ratio
167.29x
EPS (TTM)
$-2.89
Dividend yield
—
52W range
$0 – $3
Volume
3.6M
OUTLOOK THERAPEUTICS INC (OTLK) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.05M | $5.22M | $2.98M | $3.81M | $3.09M | $8.15M | $5.85M | $0.00 | $0.00 | $0.00 | $170124.00 | $1.41M |
| Revenue growth (YoY) | — | -42.3% | -42.9% | +27.9% | -19.0% | +163.8% | -28.1% | -100.0% | — | — | — | +730.9% |
| Cost of revenue | $14124.00 | $38876.00 | $32763.00 | $23.81M | $18.50M | $23.80M | $554069.00 | $262139.00 | $204694.00 | $44188.00 | $113859.00 | $756330.00 |
| Gross profit | $9.04M | $5.18M | $2.95M | $3.79M | $3.07M | $-15.66M | $-554069.00 | $-262139.00 | $-204694.00 | $-44188.00 | $-113859.00 | $657205.00 |
| Gross margin | 99.8% | 99.3% | 98.9% | 99.4% | 99.4% | -192.2% | -9.5% | — | — | — | -66.9% | 46.5% |
| R&D | $14.13M | $38.88M | $32.76M | $23.81M | $18.50M | $23.80M | $26.34M | $38.96M | $42.33M | $26.45M | $41.76M | $27.18T |
| SG&A | $7.32M | $12.91M | $21.56M | $15.88M | $14.23M | $9.37M | $9.97M | $12.77M | $20.74M | $26.67M | $29.94M | $39.94M |
| Operating income | $-12.39M | $-46.56M | $-51.35M | $-35.88M | $-29.64M | $-36.30M | $-36.84M | $-51.73M | $-63.07M | $-53.13M | $-71.70M | $-67.06M |
| Operating margin | -136.9% | -892.2% | -1723.1% | -941.2% | -960.0% | -445.6% | -629.4% | — | — | — | -42147.5% | -4744.3% |
| EBITDA | $-11.51M | $-44.74M | $-48.95M | $-30.03M | $-26.80M | $-31.11M | $-36.20M | $-51.51M | $-64.36M | $-57.38M | $-72.09M | $-63.58M |
| EBITDA margin | -127.2% | -857.2% | -1642.7% | -787.8% | -867.7% | -381.9% | -618.4% | — | — | — | -42376.8% | -4497.7% |
| EBIT | $-12.39M | $-46.56M | $-51.35M | $-32.72M | $-29.85M | $-34.47M | $-36.76M | $-51.77M | $-64.56M | $-57.42M | $-72.21M | $-63.69M |
| Interest expense | $901052.00 | $2.30M | $1.85M | $5.63M | $3.89M | $3.47M | $1.76M | $936127.00 | $1.49M | $1.56M | $3.16M | $283128.00 |
| Income tax | $439018.00 | $-190000.00 | $103000.00 | $501500.00 | $-3.65M | $-3.41M | $-3.27M | $2000.00 | $2800.00 | $2800.00 | $2800.00 | $-1.55M |
| Effective tax rate | -3.3% | 0.4% | -0.2% | -1.3% | 10.8% | 9.0% | 8.5% | -0.0% | -0.0% | -0.0% | -0.0% | 2.4% |
| Net income | $-13.73M | $-47.39M | $-53.30M | $-38.85M | $-30.09M | $-34.52M | $-35.24M | $-53.16M | $-66.05M | $-58.98M | $-75.37M | $-62.42M |
| Net income growth (YoY) | — | -245.1% | -12.5% | +27.1% | +22.5% | -14.7% | -2.1% | -50.9% | -24.2% | +10.7% | -27.8% | +17.2% |
| Profit margin | -151.7% | -908.1% | -1788.7% | -1019.1% | -974.5% | -423.8% | -602.0% | — | — | — | -44301.2% | -4416.2% |